3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
SFL, a Veristat company, is attending the 28th Annual Swiss Symposium in Pharmaceutical Medicine 2023
28th Annual Swiss Symposium in Pharmaceutical Medicine 2023, 29th November, at Musikschule, Florhofgasse 6, Zurich, Switzerland.
This year’s Annual Symposium in Pharmaceutical Medicine is focusing on Patient Engagement from the perspectives of clinical trials, drug development, and the safe use of medicinal products. It is essential that patients are properly informed using lay language summaries to enable them to make educated decisions. Drug shortages, particularly in crisis regions, are a tremendous problem, especially for patients with chronic diseases. The Symposium will bring to light these important issues and more.
Anja Buhrer, Vice President Regulatory Affairs and Deputy Head at SFL, and Delphine Guérin, Director Business Development and Project Management at SFL, a Veristat Company, are attending the Symposium. We look forward to connecting with you at the SFL booth and to discuss how we may support your projects.
Website: SwAPP Conference 2023

Meet with us at the 28th Annual Swiss Symposium in Pharmaceutical Medicine 2023 by filling out the form below.
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
3 min read
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...